Modifying TZD Drug to Improve Function in Body
Overview
Objectives/Goals This study investigates the particular interaction between the current TZD drugs and its protein active site to help propose more efficacious analogs of this drug. Computational experiments will primarily analyze the drug's stereocenter, which will further examine the importance of chirality in a drug's metabolism in the human body. Methods/Materials I first found the crystal structures of some known TZD drugs: trogliazone and rosigliatzone on the RCSB Protein Data Bank. I created the drug derivatives on Gaussview and docked those drugs with Fred Recepter with the known crystal structure. After determining the active site, I determined which drug should be the scaffold for building new drug analogs. I used this pharmacophore to construct confermers on Gauss View, which were also docked into the active site. The scores after the docking procedure proved which analogs were the more successful binding candidates. Results VIDA visualization aid helped identify which amino acids were interacting with the protein in the active site. I noticed potential hydrogen bonding or electron affinity interactions and began constructing conformers with stronger, more electronegative tails. I also tested how the new drug would interact if a functional group were to attach. I resolved that the oxygen replacement was the most promising modification. To further my research, I also looked into drug chirality, a prominent issue that pharmaceutical chemists have to face reguarly. I analyzed how each enantiomer of rosiglitazone would bind to the binding site, and as predicted, one of the enantiomers did not interact at all with the protein, which proved that enantiomers are distinct entities of the same drug. Conclusions/Discussion This drug design project focused on analyzing how certain components of a molecule interacted with its corresponding active site. I built the active site using the crystal structures given from the PDB website, and I docked my molecules into that structure. I created numerous analogs, and compared the docking scores of each one to propose the most successful modification. The oxygen I added to the aromatic ring proved to be the most useful in picking up another interaction with a neighboring amino acid, and thus it received the best score. The more negative the value, the better the docking.
Summary statement
This study investigates the particular interaction between the current TZD drugs and its protein active site to help propose more efficacious analogs of this drug.
Help received
Used Software and Computer at UC Davis under the guidance of Dr. Dean Tantillo and two of his graduate students.
Competition history
- CSEF 2010
Resources
Related projects
CSEF · 2015
Using Virtual Screening Methods to Identify a Novel and Noninvasive Method of Heart Disease Treatment and Prevention
AJAS · 2020
The Effect of Stereoisomeric Differences on Insulin Receptor Affinity
ISEF · 2017
Designing and Testing a Novel Drug Targeting the Distinct Metabolic Roles of the Isoforms of PPARGamma
CSEF · 2012
In vivo Drug Assembly
CSEF · 2018
Synthesizing Inhibitors of Isocitrate Dehydrogenase 1 to Inhibit Glutamine-Dependent Reductive Carboxylation in Tumors
CSEF · 2005
PPAR Delta Crystallography
CSEF · 2012
Modeling and Molecular Dynamics Simulations of Membrane-Bound Aromatase Reveal Novel Druggable Sites
ISEF · 2015
Using Virtual Screening Methods to Identify a Novel and Noninvasive Method of Heart Disease Treatment and Prevention
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects